Government Contract Services

In Forensics

The EY government contract consulting team delivers accounting, pricing, regulatory compliance, cost recovery and portfolio growth strategy, and dispute and litigation support for businesses that work with the federal government. Additionally, our team has specific experience supporting life sciences companies in drug pricing, 340B compliance and revenue leakage strategy.


What EY Government Contract Services can do for you

Businesses engaged with the US government must adhere to and manage regulatory complexities while optimizing program performance. With the EY suite of federal contract, financial assistance and reimbursement services, they can adroitly develop cost recovery strategies, implement governance and oversight frameworks, comply with various regulatory requirements ranging from accounting, pricing, supply chain, ethics, labor and reporting, and gain strategic dispute and litigation support in these and other areas. Additionally, for companies involved in health care reimbursement and drug discount programs, EY teams offer targeted services to enhance economic value, manage compliance risks and utilize advanced analytics to detect and address potential noncompliance and revenue leakage.

Cross-sector government contract consulting regulatory services

Clients pursuing or performing on US government contracts and grants are required to navigate the complexities of unique statutes and regulations. They often seek guidance and assistance with developing pricing, cost accounting and compliance infrastructure, all offered through EY government contract consulting. In addition, EY teams deliver support during government audits, investigations and disputes. EY services include creating and implementing operational designs, cost accounting structures, business systems and internal controls to meet government requirements.

Drug pricing and 340B program optimization

EY teams assist companies that participate in US government health care reimbursement and drug discount programs with enhancing economic value and mitigating noncompliance risk. EY services include assessing revenue management and gross-to-net operations, performing government drug pricing calculations and reporting, addressing Medicaid, Medicare and commercial rebate processing, and assessing and remediating noncompliance with applicable statutory and regulatory requirements. We employ advanced analytical tools to process large volumes of data to analyze and identify trends, anomalies, root causes of potential noncompliance and potential revenue leakage.

Solutions


IRA Inflation Rebates

IRA Inflation Rebates

Contact us
Get in touch to learn more.

Pharmaceutical Revenue Management Services

EY pharmaceutical government pricing is the cornerstone of our Pharmaceutical Revenue Management offerings. Watch this video and learn how these solutions may work for your organization.

Our latest thinking on Government Contract Services

How to navigate federal funding in the current administration

Explore how organizations can adapt to changing federal funding priorities and unlock growth under the current US administration.

How strategic controls fuel growth in government contracting

Explore how evolving compliance standards impact government contractors. Learn to implement effective controls for success in the government marketplace.

How cost simplification and restructuring can enhance competitiveness

Explore how restructuring can enhance competitiveness for government contractors. Learn key strategies to streamline operations and achieve cost savings.

What commercial companies should know before pursuing government awards

Discover key insights for commercial companies pursuing government funding. Understand compliance requirements and position your organization for success.

Transforming compliance with advanced strategies and technologies

Learn how multinationals are approaching compliance challenges and driving advancements. Read the 2024 Global Integrity Report – US edition.

How to navigate the Medicaid Drug Rebate Program proposed changes

CMS released a proposed rule aimed at revising the Medicaid Drug Rebate Program requirements. It encompasses several regulatory changes. Explore further.

MDRP proposed rule could impact 340B covered entities

340B covered entities should be aware of four changes proposed by the Centers for Medicare and Medicaid Services. Read to learn more.

How CMS proposes to compensate 340B covered entities for underpayments

A CMS proposed rule will compensate covered entities affected by the Medicare reimbursement cuts for 340B drugs. Learn more.

Beyond HRSA: 340B risks related to Medicare and Medicaid

Are 340B entities giving enough attention to non-HRSA compliance obligations? Learn more.

Why class of trade is important for government pricing calculations

Accurate class of trade assignments ensure a manufacturer calculates accurate government prices. Learn more.

How US government pricing programs affect drug product launches

Before a drug product launch, it is important for organizations to analyze how government programs can influence their products. Learn more.